Clinical Trials for KZR-616
KZR-616 is currently being evaluated in Phase 2 clinical trials for the treatment of lupus nephritis and dermatomyositis/polymyositis. Find out how KZR-616 works to harmonize the immune system.
To learn more about participating in our clinical trials, please email clinicaltrials@kezarbio.com.
Recruiting
A Phase 1b/2 Study of KZR-616 in Patients With Systemic Lupus Erythematosus with and without Nephritis
Top 5 Things to Know about KZR-616 for the Treatment of LN
More Information